The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Alzheimer's Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments
Open accessAbstract
There is an urgent need to find effective presymptomatic Alzheimer's disease (AD) treatments that reduce the risk of AD symptoms or prevent them completely. It currently takes too many healthy people, too much money and too many years to evaluate the range of promising presymptomatic treatments using clinical endpoints. We have used brain imaging and other measurements to track some of the earliest changes associated with the predisposition to AD. We have proposed the Alzheimer's Prevention Initiative (API) to evaluate investigational amyloid-modifying treatments in healthy people who, based on their age and genetic background, are at the highest imminent risk of developing symptomatic AD using brain imaging, cerebrospinal fluid (CSF), and cognitive endpoints. In one trial, we propose to study AD-causing presenilin 1 [PS1] mutation carriers from the world's largest early-onset AD kindred in Antioquia, Colombia, close to their estimated average age at clinical onset. In another trial, we propose to study apolipoprotein E (APOE) ε4 homozygotes (and possibly heterozygotes) close to their estimated average age at clinical onset. The API has several goals: 1) to evaluate investigational AD-modifying treatments sooner than otherwise possible; 2) to determine the extent to which the treatment's brain imaging and other biomarker effects predict a clinical benefit-information needed to help qualify biomarker endpoints for use in pivotal prevention trials; 3) to provide a better test of the amyloid hypothesis than clinical trials in symptomatic patients, when these treatments may be too little too late to exert their most profound effect; 4) to establish AD prevention registries needed to support these and other presymptomatic AD trials; and 5) to give those individuals at highest imminent risk of AD symptoms access to the most promising investigational treatments in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citationBiomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Shumaker, S. A., Legault, C., Rapp, S. R., Thal, L., Wallace, R. B., Ockene, J. K., Hendrix, S. L., Jones III, B. N., Assaf, A. R., Jackson, R. D., et al. (2003) · JAMA · doi:10.1001/jama.289.20.2651 · Cited by 2,178
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Effects of Cognitive Training Interventions With Older Adults: A Randomized Controlled Trial
Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., Morris, J. N., Rebok, G. W., Smith, D. M., Tennstedt, S. L., et al. (2002) · JAMA · doi:10.1001/jama.288.18.2271 · Cited by 2,049
Brookmeyer, R., Gray, S., & Kawas, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,787
Surrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
Lautenschlager, N. T., Cox, K. L., Flicker, L., Foster, J. K., van Bockxmeer, F. M., Xiao, J., Greenop, K. R., & Almeida, O. P. (2008) · JAMA · doi:10.1001/jama.300.9.1027 · Cited by 1,637
Alzheimer’s Disease Neuroimaging Initiative
Mueller, S. G., Weiner, M. W., Thal, L. J., Petersen, R. C., Jack, C., Jagust, W., Trojanowski, J. Q., Toga, A. W., & Beckett, L. (2007) · Advances in Behavioral Biology · doi:10.1007/978-0-387-72076-0_18 · Cited by 1,468
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Self-citationPatterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
Wada, K., Tanaka, K., & Nakashima, K. (2011) · PubMed · Cited by 1,132
Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
Reiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2635903100 · Cited by 977
Self-citationWang, H.-X. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.12.1081 · Cited by 967
Physical Activity, Diet, and Risk of Alzheimer Disease
Scarmeas, N. (2009) · JAMA · doi:10.1001/jama.2009.1144 · Cited by 916
Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.noc60123 · Cited by 897
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease
Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785
Self-citationDeKosky, S. T. (2008) · JAMA · doi:10.1001/jama.2008.683 · Cited by 670
Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study
Fox, N. C., Warrington, E. K., Freeborough, P. A., Hartikainen, P., Kennedy, A. M., Stevens, J. M., & Rossor, M. N. (1996) · Brain · doi:10.1093/brain/119.6.2001 · Cited by 656
Small, G. W. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520360056039 · Cited by 604
Bateman, R. J., Aisen, P. S., De Strooper, B., Fox, N. C., Lemere, C. A., Ringman, J. M., Salloway, S., Sperling, R. A., Windisch, M., & Xiong, C. (2010) · Alzheimer's Research & Therapy · doi:10.1186/alzrt59 · Cited by 573
Longitudinal Modeling of Age-Related Memory Decline and the APOE ε4 Effect
Caselli, R. J., Dueck, A. C., Osborne, D., Sabbagh, M. N., Connor, D. J., Ahern, G. L., Baxter, L. C., Rapcsak, S. Z., Shi, J., Woodruff, B. K., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809437 · Cited by 528
Self-citationLemere, C. A., Lopera, F., Kosik, K. S., Lendon, C. L., Ossa, J., Saido, T. C., Yamaguchi, H., Ruiz, A., Martinez, A., Madrigal, L., et al. (1996) · Nature Medicine · doi:10.1038/nm1096-1146 · Cited by 487
Self-citationGAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers
Reiman, E. M., Webster, J. A., Myers, A. J., Hardy, J., Dunckley, T., Zismann, V. L., Joshipura, K. D., Pearson, J. V., Hu-Lince, D., Huentelman, M. J., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.022 · Cited by 487
Self-citationReiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061509598 · Cited by 467
Self-citationReiman, E. M., Chen, K., Alexander, G. E., Caselli, R. J., Bandy, D., Osborne, D., Saunders, A. M., & Hardy, J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500579102 · Cited by 401
Self-citationHaag, M. D. M., Hofman, A., Koudstaal, P. J., Stricker, B. H. C., & Breteler, M. M. B. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.150433 · Cited by 393
Lopera, F. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340027028 · Cited by 351
Self-citationBiomarkers and surrogate markers: An FDA perspective
Katz, R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.189 · Cited by 347
Visual short-term memory binding deficits in familial Alzheimer’s disease
Parra, M. A., Abrahams, S., Logie, R. H., Méndez, L. G., Lopera, F., & Della Sala, S. (2010) · Brain · doi:10.1093/brain/awq148 · Cited by 313
Self-citation(2006) · PubMed · Cited by 269
Acosta-Baena, N., Sepulveda-Falla, D., Lopera-Gómez, C. M., Jaramillo-Elorza, M. C., Moreno, S., Aguirre-Acevedo, D. C., Saldarriaga, A., & Lopera, F. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70323-9 · Cited by 263
Self-citationHippocampal hyperactivation in presymptomatic familial Alzheimer's disease
Quiroz, Y. T., Budson, A. E., Celone, K., Ruiz, A., Newmark, R., Castrillón, G., Lopera, F., & Stern, C. E. (2010) · Annals of Neurology · doi:10.1002/ana.22105 · Cited by 253
Self-citationLongitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele
Caselli, R. J., Reiman, E. M., Osborne, D., Hentz, J. G., Baxter, L. C., Hernandez, J. L., & Alexander, G. G. (2004) · Neurology · doi:10.1212/01.wnl.0000129533.26544.bf · Cited by 229
Self-citationBurggren, A. C., Zeineh, M. M., Ekstrom, A. D., Braskie, M. N., Thompson, P. M., Small, G. W., & Bookheimer, S. Y. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.03.039 · Cited by 217
Sperling, R. A., Aisen, P. S. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J. A., Montine, T. J., et al. (2011) · Cited by 197
Self-citationReducing the Risk of Dementia: Efficacy of Long-Term Treatment of Hypertension
Peila, R., White, L. R., Masaki, K., Petrovitch, H., & Launer, L. J. (2006) · Stroke · doi:10.1161/01.str.0000217653.01615.93 · Cited by 181
Report of the task force on designing clinical trials in early (predementia) AD
Aisen, P. S., Andrieu, S., Sampaio, C., Carrillo, M., Khachaturian, Z. S., Dubois, B., Feldman, H. H., Petersen, R. C., Siemers, E., Doody, R. S., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318207b1b9 · Cited by 172
Chen, K., Langbaum, J. B. S., Fleisher, A. S., Ayutyanont, N., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G. E., Thompson, P. M., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.02.064 · Cited by 169
Self-citationCharacterizing Alzheimer's disease using a hypometabolic convergence index
Chen, K., Ayutyanont, N., Langbaum, J. B. S., Fleisher, A. S., Reschke, C., Lee, W., Liu, X., Bandy, D., Alexander, G. E., Thompson, P. M., et al. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.01.049 · Cited by 162
Self-citationReiman, E. M., Langbaum, J. B. S., & Tariot, P. N. (2010) · Biomarkers in Medicine · doi:10.2217/bmm.09.91 · Cited by 162
Self-citationCaselli, R. J., Reiman, E. M., Locke, D. E. C., Hutton, M. L., Hentz, J. G., Hoffman‐Snyder, C., Woodruff, B. K., Alexander, G. E., & Osborne, D. (2007) · Archives of Neurology · doi:10.1001/archneur.64.9.1306 · Cited by 155
Self-citationValla, J., Yaari, R., Wolf, A. B., Kusne, Y., Beach, T. G., Roher, A. E., Corneveaux, J. J., Huentelman, M. J., Caselli, R. J., & Reiman, E. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100129 · Cited by 150
Self-citationGómez‐Isla, T., Growdon, W. B., McNamara, M. J., Nochlin, D., Bird, T. D., Arango, J. C., Lopera, F., Kosik, K. S., Lantos, P. L., Cairns, N. J., et al. (1999) · Brain · doi:10.1093/brain/122.9.1709 · Cited by 131
Self-citationPreclinical memory decline in cognitively normal apolipoprotein E–ε4 homozygotes
Caselli, R. J., Graff‐Radford, N. R., Reiman, E. M., Weaver, A., Osborne, D., Lucas, J. A., Uecker, A., & Thibodeau, S. N. (1999) · Neurology · doi:10.1212/wnl.53.1.201 · Cited by 123
Self-citationSzekely, C. A., Green, R. C., Breitner, J. C. S., Østbye, T., Beiser, A. S., Corrada, M. M., Dodge, H. H., Ganguli, M., Kawas, C. H., Kuller, L. H., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000313933.17796.f6 · Cited by 121
Correlations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates
Chen, K., Reiman, E. M., Alexander, G. E., Caselli, R. J., Gerkin, R. D., Bandy, D. J., Domb, A., Osborne, D., Fox, N. C., Crum, W. R., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.916 · Cited by 121
Self-citationThe Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes
Beckett, L. A., Harvey, D. J., Gamst, A. C., Donohue, M., Kornak, J., Zhang, H., Kuo, J. H., & Initiative, A. D. N. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.03.002 · Cited by 120
Evidence for an association between KIBRA and late-onset Alzheimer's disease
Corneveaux, J. J., Liang, W. S., Reiman, E. M., Webster, J., Myers, A., Zismann, V., Joshipura, K. D., Pearson, J. V., Hu‐Lince, D., Craig, D. W., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.014 · Cited by 116
Self-citationArdila, A., Lopera, F., Rosselli, M., Moreno, S., Madrigal, L., Arango-Lasprilla, J. C., Arcos, M., Murcia, C., Arango-Viana, J. C., Ossa, J., et al. (2000) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/15.6.515 · Cited by 113
Self-citationParra, M. A., Sala, S. D., Abrahams, S., Logie, R. H., Méndez, L., & Lopera, F. J. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2011.03.022 · Cited by 113
Self-citationCaselli, R. J., Chen, K., Lee, W., Alexander, G. E., & Reiman, E. M. (2008) · Archives of Neurology · doi:10.1001/archneurol.2008.1 · Cited by 106
Self-citationLinguistic changes in verbal expression: A preclinical marker of Alzheimer's disease
CUETOS, F., ARANGO-LASPRILLA, J. C., URIBE, C., VALENCIA, C., & LOPERA, F. (2007) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617707070609 · Cited by 102
Self-citationLangbaum, J. B. S., Chen, K., Caselli, R. J., Lee, W., Reschke, C., Bandy, D., Alexander, G. E., Burns, C. M., Kaszniak, A. W., Reeder, S. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.30 · Cited by 100
Self-citationDifferential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease
Dorfman, V. B., Pasquini, L. A., Riudavets, M. A., López‐Costa, J. J., Villegas, A., Troncoso, J. C., Lopera, F. J., Castaño, E. M., & Morelli, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.09.016 · Cited by 94
Self-citationTwo-year follow-up of amyloid deposition in patients with Alzheimer's disease
Klunk, W. E., Mathis, C. A., Price, J. C., Lopresti, B. J., & DeKosky, S. T. (2006) · Brain · doi:10.1093/brain/awl281 · Cited by 83
Presenilin-1–associated abnormalities in regional cerebral perfusion
Johnson, K. A., Lopera, F. J., Jones, K., Becker, A., Sperling, R. A., Hilson, J., Londono, J., Siegert, I., Arcos‐Burgos, M., Moreno, S., et al. (2001) · Neurology · doi:10.1212/wnl.56.11.1545 · Cited by 76
Self-citationNongenetic Factors as Modifiers of the Age of Onset of Familial Alzheimer’s Disease
Mejía-Arango, S., Giraldo, M., Pineda, D. A., Lopera, F. J., & Ardila, A. (2003) · International Psychogeriatrics · doi:10.1017/s1041610203009591 · Cited by 75
Self-citationReiman, E. M., Chen, K., Langbaum, J. B. S., Lee, W., Reschke, C., Bandy, D. J., Alexander, G. E., & Caselli, R. J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.07.025 · Cited by 73
Self-citationChen, K., Reiman, E. M., Huan, Z., Caselli, R. J., Bandy, D. J., Ayutyanont, N., & Alexander, G. E. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.053 · Cited by 70
Self-citationCaselli, R. J., Osborne, D., Reiman, E. M., Hentz, J. G., Barbieri, C. J., Saunders, A. M., Hardy, J., Graff‐Radford, N. R., Hall, G. R., & Alexander, G. E. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00577-9 · Cited by 62
Self-citationCerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes
Caselli, R. J., Dueck, A. C., Locke, D. E. C., Sabbagh, M. N., Ahern, G. L., Rapcsak, S. Z., Baxter, L. C., Yaari, R., Woodruff, B. K., Hoffman‐Snyder, C., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318211c3ae · Cited by 60
Self-citationList of Drugs in Development for Neurodegenerative Diseases
Fischer, F., Matthisson, M., & Herrling, P. L. (2004) · Neurodegenerative Diseases · doi:10.1159/000077879 · Cited by 53
Early Detection of Alzheimer's Disease by Combining Apolipoprotein E and Neuroimaginga
Small, G. W., Komo, S., Rue, A. L., Saxena, S., Phelps, M. E., Mazziotta, J. C., Saunders, A. M., Haines, J. L., Pericak‐Vance, M. A., & Roses, A. D. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb32600.x · Cited by 52
Chen, K., Reiman, E. M., Alexander, G. E., Bandy, D. J., Renaut, R. A., Crum, W. R., Fox, N. C., & Rossor, M. N. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.01.002 · Cited by 51
Self-citationZandi, P. P. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.82 · Cited by 47
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009
Khachaturian, Z. S., Barnes, D. E., Einstein, R., Johnson, S. C., Lee, V., Roses, A. D., Sager, M. A., Shankle, W. R., Snyder, P. J., Petersen, R. C., et al. (2010) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.01.008 · Cited by 44
Self-citationERP generator anomalies in presymptomatic carriers of the Alzheimer's disease E280APS‐1mutation
Bobes, M. A., García, Y. F., Lopera, F. J., Quiroz, Y. T., Galán, L., Vega, M., Trujillo‐Barreto, N. J., Valdés-Sosa, M. J., & Valdes-Sosa, P. A. (2009) · Human Brain Mapping · doi:10.1002/hbm.20861 · Cited by 43
Self-citationCognitive changes in the preclinical phase of familial Alzheimer's disease
Arango‐Lasprilla, J. C., Cuetos, F., Valencia, C., Uribe, C., & Lopera, F. J. (2007) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390601174151 · Cited by 41
Self-citationRosselli, M., Ardila, A., Moreno, S., Standish, V., Arango‐Lasprilla, J. C., Tirado, V., Ossa, J. E., Goate, A., Kosik, K. S., & Lopera, F. (2000) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/1380-3395(200008)22:4;1-0;ft483 · Cited by 31
Self-citationReiman, E. M., Chen, K., Caselli, R. J., Alexander, G. E., Bandy, D. J., Adamson, J. L., Lee, W., Cannon, A. D., Stephan, E. A., Stephan, D. A., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2007.12.066 · Cited by 31
Self-citationList of Drugs in Development for Neurodegenerative Diseases: Update June 2009
Pogačić, V., & Herrling, P. L. (2009) · Neurodegenerative Diseases · doi:10.1159/000232576 · Cited by 29
Reiman, E. M., Caselli, R. J., Alexander, G. E., & Chen, K. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00006-8 · Cited by 28
Self-citationLiang, W. S., Chen, K., Lee, W., Sidhar, K., Corneveaux, J. J., Allen, A. N., Myers, A., Villa, S., Meechoovet, B., Pruzin, J. J., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.09.066 · Cited by 23
Self-citationArango‐Lasprilla, J. C., Iglesias, J., & Lopera, F. J. (2003) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750301800306 · Cited by 21
Self-citationReiman, E. M., & Langbaum, J. B. S. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328875.003.0020 · Cited by 16
Self-citationE280A PS-1 mutation causes Alzheimer's disease but age of onset is not modified by ApoE alleles
Lendon, C. L., Martinez, A., Behrens, I. M., Kosik, K. S., Madrigal, L., Norton, J., Neuman, R., Myers, A., Busfield, F., Wragg, M., et al. (1997) · Human Mutation · doi:10.1002/(sici)1098-1004(1997)10:3
Self-citation
Cited by
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
Scheltens, P., Blennow, K., Breteler, M. M. B., de Strooper, B., Frisoni, G. B., Salloway, S., & Van der Flier, W. M. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01124-1 · Cited by 3,125
Lane, C. A., Hardy, J., & Schott, J. M. (2018) · European Journal of Neurology · doi:10.1111/ene.13439 · Cited by 2,616
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
Hampel, H., Mesulam, M.-M., Cuello, A. C., Farlow, M. R., Giacobini, E., Grossberg, G. T., Khachaturian, A. S., Vergallo, A., Cavedo, E., Snyder, P. J., et al. (2018) · Brain · doi:10.1093/brain/awy132 · Cited by 1,918
Preclinical Alzheimer’s Disease: Definition, Natural History, and Diagnostic Criteria
Dubois, B., Hampel, H., Feldman, H. H., Scheltens, P., Aisen, P., Andrieu, S., Bakardjian, H., Benali, H., Bertram, L., Blennow, K., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.02.002 · Cited by 1,925
Metadata
- Authors
- Reiman, E. M., Langbaum, J. B. S., Fleisher, A. S., Caselli, R. J., Chen, K., Ayutyanont, N., Quiroz, Y. T., Kosik, K. S., Lopera, F., & Tariot, P. N.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2011-10-04
- Volume
- 26
- Issue
- s3
- Pages
- 321-329
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2131328232
- Cited by
- 339
- References
- 82
- FWCI
- 16.95
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.